# clm_8BF1DFD17C30

subject: Bristol-Myers Squibb (/record/bristol-myers-squibb.md)  
predicate: quarterly_research_and_development  
value: 2,580,000,000 United States dollar  
valid_from: 2025-06-30  
valid_to: 2025-09-30  
published: 2025-07-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_F60212FAE72C  
last_updated: 2026-11-08  
cite: AsOf. "Bristol-Myers Squibb quarterly research and development: 2,580,000,000 United States dollar", as of 2025-06-30 (until 2025-09-30). Claim clm_8BF1DFD17C30, https://asof.is/claim/clm_8BF1DFD17C30, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2025, filed 2025-07-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm (primary, SEC EDGAR 10-Q Q2 FY2025, published 2025-07-31)

## Supersedes

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,257,000,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_8BF1DFD17C30](/claim/clm_8BF1DFD17C30.md) | [clm_521ADD71267C](/claim/clm_521ADD71267C.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.